Christophe Lonchay

Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen

Christophe Lonchay, Pierre van der Bruggen, Thierry Connerotte et al. · Proceedings of the National Academy of Sciences · 2004 · 148 citations · Full text

Life Sciences, Immunology, Oncology +17

Oral mucositis induced by anticancer treatments: physiopathology and treatments

Lionel D’Hondt, Christophe Lonchay, Marc Andr� et al. · Therapeutics and Clinical Risk Management · 2006 · 89 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Antigen‐independent accumulation of activated effector/memory T lymphocytes into human and murine tumors

Nathalie T. Joncker, Marie‐Annick Marloie, Anna Chernysheva et al. · International Journal of Cancer · 2005 · 26 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck

Emmanuel Seront, Sandra Schmitz, M. Papier et al. · Frontiers in Oncology · 2019 · 22 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy

Jean‐Pascal Machiels, Aline van Maanen, Jean‐Marie Vandenbulcke et al. · The Oncologist · 2016 · 17 citations · Full text

Medicine, Oncology, Pharmacology +16